Latest filing published 01 Apr 2008 for Molecular Insight Pharmaceuticals, Inc., €7,931.
Insider track record
No signal scores available.
Joshua Hamermesh: trading record in brief
All filings by Joshua Hamermesh on record concern Molecular Insight Pharmaceuticals, Inc. The record holds 3 filings, for trades running from 19 June 2007 to 31 March 2008.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 1 April 2008 with an option exercise (€7,931) in Molecular Insight Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joshua Hamermesh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,166 shares@ US$3.00Common StockSEC:0001209191-08-020988:0
- 8,334 shares@ US$3.00Common StockSEC:0001209191-08-020213:0
- 8,333 shares@ US$3.00Common StockSEC:0001209191-07-038095:0
3 of 3 declarations
